BrachaShayVetMedMultiplexBiomarkerApproach_Figures1-5.zip

Citeable URL: https://ir.library.oregonstate.edu/concern/articles/44558k47d

Descriptions

Attribute Name	Values
Creator	Bracha, Shay McNamara, Michael Hilgart, Ian Milovancev, Milan Medlock, Jan Goodall, Cheri Wickramasekara, Samanthi Maier, Claudia S.
Abstract	Transitional cell carcinoma (TCC), the most common cancer of the urinary bladder in dogs, is usually diagnosed at an advanced disease stage with limited response to chemotherapy. Commercial screening tests lack specificity and current diagnostic procedures are invasive. A proof of concept pilot project for analyzing the canine urinary proteome as a non-invasive diagnostic tool for TCC identification was conducted. Urine was collected from 12 dogs in three cohorts (healthy, urinary tract infection, TCC) and analyzed using liquid chromatography tandem mass spectrometry. The presence of four proteins (macrophage capping protein, peroxiredoxin 5, heterogeneous nuclear ribonucleoproteins A2/B, and apolipoprotein A1) was confirmed via immunoblot. Of the total 379 proteins identified, 96 were unique to the TCC group. A statistical model, designed to evaluate the accuracy of this multiplex biomarker approach for diagnosis of TCC, predicted the presence of disease with 90% accuracy. Keywords: Transitional cell carcinoma, Liquid chromatography, Tandem mass spectrometry, Canine, Biomarkers Keywords: Transitional cell carcinoma, Liquid chromatography, Tandem mass spectrometry, Canine, Biomarkers
Rights Statement	Copyright Not Evaluated
Accessibility Feature	unknown